Pharmaceutical manufacturers are accelerating investment in direct-to-patient models as policy shifts and rising consumer expectations reshape the industry landscape. Chip Parkinson, CEO of Gifthealth, says the momentum behind these integrated models has
Investors searching for income are increasingly turning to FTSE 250 stocks as Cash ISA rates continue to disappoint savers across the United Kingdom. One particular FTSE 250 stock has drawn attention for
MoreHengrui Pharma and Elevar Therapeutics have received a third complete response letter from the FDA for their camrelizumab and rivoceranib combination therapy. The rejection marks more than two years of regulatory setbacks
MoreThe Supreme Court’s June 25, 2026, decision in Monsanto Company v. Durnell marks the most significant interpretation of FIFRA’s preemption provision since the earlier Bates v. Dow Agrosciences ruling. The landmark ruling
MoreThe Supreme Court’s October Term 2025 delivered consequential rulings for environmental law, even though environmental cases were not the central focus of the merits docket. The Court’s decisions addressed foundational issues including
MoreLondon equities managed modest gains on Monday as rising oil prices lifted energy stocks, helping the market absorb fresh geopolitical shock from renewed U.S. military action against Iran. The FTSE 100 rose
MoreGreggs (GRG) has been a frustrating holding for many retail investors, with shares underperforming expectations over a prolonged period. The British bakery chain, once celebrated as one of the UK stock market’s
MoreBioMarin has launched a three-episode video podcast series called “Why Do I Pheel This Way?” aimed at teens living with phenylketonuria, known as PKU. The campaign centres on real conversations about the
MoreOn July 7, 2026, the Federal Reserve Board requested public comment on a proposed rule targeting anti-money laundering and countering the financing of terrorism program requirements. The proposal would amend Regulation H
MoreOn June 16, the Commodity Futures Trading Commission issued a Request for Information seeking public comment on whether its existing regulations unnecessarily hinder fintech firms. The initiative asks whether current CFTC rules,
MoreDRDGOLD (NYSE: DRD) appears to be holding its ground on valuation metrics even as gold prices face renewed selling pressure in global markets. The South Africa-based gold producer has attracted analyst attention
More
